Nutritional and Metabolic Diseases

441 trials 157 recruiting

Filter these 441 trials by phase, country and sponsor.

Open in Search →

A Phase 1 Study of WVE-007 in Adults Living with Overweight or Obesity Recruiting

2024-520203-41-00 Adults Living with Overweight and Obesity 1 2025-07-25
Study to evaluate the comparative efficacy of LacTEST for the diagnosis of hypolactasia in children presenting symptoms of lactose intoleran… Recruiting

2025-521294-13-00 Lactose intolerance 6 2025-07-14
Searching simple biomarkers to phenotype type 2 diabetic patients and personalize their treatment Recruiting

2024-516542-19-00 type 2 diabetes 6 2025-07-08
Study to compare the efficacy and safety of a 12-week administration of two fixed-dose combinations (Rosuvastatin 20 mg and Fenofibrate 160 … Recruiting

2024-514289-38-00 Dyslipidaemia 5 2025-06-26
Comparison of inclisiran or alirocumab to standard therapy in pediatric heterozygous familial hypercholesterolemia (HeFH) – the head-to-head… Recruiting

2024-514523-42-00 heterozygous familial hypercholesterolemia 5 2025-06-05
Pilot Study of Liver Fibrosis Stage Assessment by Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nona… Recruiting

2024-511788-27-01 non-alcoholic hepatic steatosisalcoholic hepatic steato 4 2025-06-03
The Role of the Amylin Analogue Cagrilintide in Bone Metabolism Recruiting

2024-517883-49-00 Female (aged between 50-70 years (both included)) with 3 2025-05-28
Differences in absorption via oral route and via oral mucosa of hydrocortisone from 2-dimensionally printed dissolvable films in healthy vol… Recruiting

2024-517298-26-00 adrenal insufficiency 2 2025-05-21
A Study of LY4057996 in Healthy Participants and Participants with Type 1 and Type 2 Diabetes (YKAA) Recruiting

2024-519151-28-00 Healthy, Diabetes Mellitus, Type 1 Diabetes Mellitus, T 1 2025-05-14
Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia Trial Recruiting

2024-511828-14-00 Type II diabetes melittus (10067585) 4 2025-05-13
A study investigating the safety of RO7795081 and the effect of RO7795081 on how the body processes different approved medications. RO779508… Recruiting

2024-519277-18-00 Obesity or Overweight 3 2025-05-08
Role of BCAA in glucose homeostasis Recruiting

2023-503424-12-00 Type 2 diabetes 6 2025-04-14
PLUTO - Prevention of CKD progression in type 1 diabetes with Long term Use of SGLTi avoiding kidney hypOxia Recruiting

2023-509450-55-01 Type 1 Diabetes Mellitus with chronic kidney complicati 4 2025-04-01
eHealth Based treatment of AdolescenT obesiTy with Low energy diet and sEmaglutide (eBATTLE Obesity) Recruiting

2023-506289-29-00 Obesity 6 2025-02-28
A multicenter, randomized, blinded, placebo controlled, phase II study to evaluate the safety and efficacy of cell therapy based with artifi… Recruiting

2023-505226-33-00 Presymptomatic diabetes type 1 (stage 1) 4 2025-01-28
A study to investigate the safety and efficacy of GSK4532990 compared with placebo in adult participants aged 18 to 65 years with alcohol-re… Recruiting

2024-511596-15-00 Liver Diseases, Alcoholic 4 2024-12-26
PROMETEO-HG Recruiting

2024-516561-37-01 Metabolic Associated Fatty Liver Disease with prediabet 5 2024-12-19
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Compensate… Recruiting

2024-512895-36-00 Metabolic Dysfunction-Associated Steatohepatitis (MASH) 5 2024-11-25
Effectiveness of ambroxol in children and adults with Gaucher disease 3: n-of-1 series Recruiting

2024-514012-28-00 Gaucher disease type 3 5 2024-11-25
LAMAinDiab - comparison of 2 pharmacological therapies (lisdexamphetamine vs methylphenidate) for pediatric patients with ADHD and type 1 di… Recruiting

2023-506862-30-00 Attention-deficit hyperactivity disorder 4 2024-11-24
WJMSC-P01 Recruiting

2024-518270-14-00 Type 1 diabetes 4 2024-11-12
Efficacy and safety trial of GNT0003 following imlifidase pre-treatment in participants aged 16 years and older with severe Crigler-Najjar s… Recruiting

2023-510405-18-00 Crigler-Najjar syndrome 4 2024-11-08
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-fibrosis) Recruiting

2023-509912-27-00 Metabolic Dysfunction-Associated Steatotic Liver Diseas 5 2024-11-07
GSDIa Disease Monitoring Program Recruiting

2023-510219-20-00 Glycogen storage disease type Ia (GSDIa) 11 2024-11-04